Premium Information is available for this item - Upgrade for $1 a day
6505-01-562-6834
Usp Dextrose Injection
6505015626834 015626834 2B0124 NDC 0338-0711-13 0724625 ADB0213 GLUCOSE 20% 500ML SOL.PERF. 5413760000336
January 2023
4
Marketplace 6505-01-562-6834
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-562-6834 2+ Documents (More...)
6505-01-562-6834 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-562-6834
/us 6505-01-562-6834 /us 6505-01-562-6834 /us 6505-01-562-6834 /us 6505-01-562-6834 /us 6505-01-562-6834
Usp Dextrose Injection 6505015626834,2B0124 -6834 /us 6505-01-562-6834 /us 6505-01-562-6834 https
Restrictions 6505-01-562-6834
6505-01-562-6834 is a Usp Dextrose Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-562-6834
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-562-6834
- Belgium (ZB01)
- Effective Date:
- 1 Apr 2008
Approved Sources 6505-01-562-6834
- Part Number
- Manufacturer
- Status
- 2B0124
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Primary Buy
- Primary Buy
- NDC 0338-0711-13
- 04687 - Baxter Healthcare Corp (Active)
- Secondary Buy
- Secondary Buy
- 0724625
- B1370 - Baxter Belgium (Active)
- Secondary Buy
- Secondary Buy
- ADB0213
- B1370 - Baxter Belgium (Active)
- Secondary Buy
- Secondary Buy
- GLUCOSE 20% 500ML SOL.PERF.
- B1370 - Baxter Belgium (Active)
- Secondary Buy
- Secondary Buy
- 5413760000336
- B1370 - Baxter Belgium (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6505-01-562-6834
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Bag, Plastic
- Special Features [FEAT]
- 20 Percent Injection,684 Caloric Content,500 Ml In 1,000 Ml Units,Ph: 4.0
NATO Stock Numbers Related to 6505-01-562-6834
Freight Information 6505-01-562-6834
6505-01-562-6834 has freight characteristics.. 6505-01-562-6834 has a variance between NMFC and UFC when transported by rail and the description should be consulted.